US Stock MarketDetailed Quotes

EVFM Evofem Biosciences

0.070 0.0000.00% Close 12/06 16:00 ET

About Evofem Biosciences Company

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.

Company Profile

Company NameEvofem Biosciences
Listing Date11/20/2014
Issue Price14.00
CEOMs. Saundra Pelletier
MarketPink Market
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address7770 Regents Road,Suite 113-618
CitySan Diego
CountryUnited States of America
Zip Code92122

Company Executives

  • Name
  • Position
  • Salary
  • Saundra Pelletier
  • Interim Chairman of the Board, President and Chief Executive Officer
  • 3.19M
  • Justin J. File
  • Chief Financial Officer and Principal Accounting Officer
  • 1.26M
  • Alexander A. Fitzpatrick, Esq.
  • General Counsel and Secretary
  • 1.05M
  • Colin Rutherford
  • Independent Director
  • 158.23K
  • Dr. Kim P. Kamdar
  • Independent Director
  • 159.48K
  • Dr. Gillian Greer, PhD
  • Independent Director
  • 150.73K
  • Tony O’Brien
  • Independent Director
  • 163.23K
  • Dr. Lisa Dale Rarick, F.A.C.O.G.
  • Independent Director
  • 140.35K
  • Jenny Yip
  • Independent Director
  • --